Evaluation of the synergistic antifungal activity of Elettaria cardamomum extract in combination with Amphotericin B, Clotrimazole, and Ketoconazole against oral Candida species: an in vitro study

Devika P. S.; Ierene Anna Sajan; S. Athulya; Harish Kumar K. S.

doi:10.18203/2320-6012.ijrms20260620

Authors

Devika P. S. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
Ierene Anna Sajan Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
S. Athulya Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India
Harish Kumar K. S. Department of Medical Microbiology, School of Medical Education, Centre for Professional and Advanced Studies, Kottayam, Kerala, India https://orcid.org/0000-0002-0504-7794

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260620

Keywords:

Amphotericin B, Clotrimazole, Ketoconazole, Elettaria cardamomum extract, Candida species, Checkerboard microbroth dilution assay, Synergy, Additive, Indifference, Antagonism, FICI

Abstract

Background: The growing incidence of antifungal resistance in Candida species presents a major clinical concern, highlighting the need for alternative therapeutic strategies. This study aimed to evaluate the synergistic potential of Elettaria cardamomum extract (ECE) in combination with conventional antifungals-amphotericin B, clotrimazole, and ketoconazole - against oral Candida isolates, to enhance antifungal efficacy.

Methods: A cross-sectional study was conducted from June 2024 to June 2025, including 161 clinical isolates of Candida species obtained from oral cavity. Identification was performed using standard mycological techniques. Antifungal susceptibility testing of ECE alone and in combination with standard drugs was carried out using the checkerboard microbroth dilution method. Fractional Inhibitory Concentration Index (FICI) were calculated to interpret the type of interaction - synergy, additive, indifference, or antagonism and statistical analyses compared susceptibility profiles between clinical isolates and control strain.

Results: ECE significantly potentiated the activity of azole antifungals, particularly ketoconazole, across all Candida species. The ketoconazole and ECE combination showed the highest synergy in C. albicans, with additive or synergistic interactions also observed in C. tropicalis and P. Kudriavzevii. Clotrimazole and ECE exhibited additive to moderate synergy, while amphotericin B and ECE combinations were largely indifferent or antagonistic. Clinical isolates exhibited higher MICs and lower synergy compared to control strains, indicating resistance trends.

Conclusions: ECE combined with imidazole antifungals demonstrated promising synergistic or additive activity, suggesting potential benefits such as reduced dosage, minimized toxicity, and delayed resistance. Further studies on phytochemical profiling, optimized formulations, and in vivo validation are warranted to support clinical application.

Metrics

Metrics Loading ...

References

de Oliveira Santos GC, Vasconcelos CC, Lopes AJO, de Sousa Cartágenes MDS, Filho AKDB, do Nascimento FRF, et al. Candida infections and therapeutic strategies: Mechanisms of action for traditional and alternative agents. Front Microbiol. 2018;9:1351. DOI: https://doi.org/10.3389/fmicb.2018.01351

Grela E, Zdybicka-Barabas A, Pawlikowska-Pawlega B, Cytryńska M. Modes of the antibiotic activity of amphotericin B against Candida albicans. Sci Rep. 2019;9:17029. DOI: https://doi.org/10.1038/s41598-019-53517-3

Hamill RJ. Amphotericin B formulations: A comparative review of efficacy and toxicity. Drugs. 2013;73(9):919–34. DOI: https://doi.org/10.1007/s40265-013-0069-4

Van Tyle JH. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984;4(6):343-73. DOI: https://doi.org/10.1002/j.1875-9114.1984.tb03398.x

Li Y, Jiao P, Li Y, Gong Y, Chen X, Sun S. The synergistic antifungal effect and potential mechanism of D-penicillamine combined with fluconazole against Candida albicans. Front Microbiol. 2019;10:2853. DOI: https://doi.org/10.3389/fmicb.2019.02853

Newman DJ, Cragg GM. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020;83(3):770-803. DOI: https://doi.org/10.1021/acs.jnatprod.9b01285

Tiwari N, Sivakumar A. Synergistic antifungal potential of fluconazole-based cardamom oil oral microemulsion formulation against C. albicans. J Res Pharm. 2022;26(5):1065-83. DOI: https://doi.org/10.29228/jrp.204

Ashokkumar K, Murugan M, Dhanya MK, Warkentin TD. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton] - A critical review. J Ethnopharmacol. 2020;246:112244. DOI: https://doi.org/10.1016/j.jep.2019.112244

Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. 4th Ed. CLSI standard M27. Wayne, PA: CLSI; 2017.

Schwalbe, R., Steele-Moore, L., & Goodwin, A.C. (Eds). Antimicrobial Susceptibility Testing Protocols (1st ed.). CRC Press; 2007. DOI: https://doi.org/10.1201/9781420014495

Vijayalakshmi P, Thenmozhi S, Rajeswari P. The Evaluation of the virulence factors of clinical Candida isolates and the anti-biofilm activity of Elettaria cardamomum against multi-drug resistant Candida albicans. Curr Med Mycol. 2016;2(2):8-15. DOI: https://doi.org/10.18869/acadpub.cmm.2.2.3

Noumi E, Snoussi M, Alreshidi MM, Rekha PD, Saptami K, Caputo L, et al. Chemical and Biological Evaluation of Essential Oils from Cardamom Species. Molecules. 2018;23(11):2818. DOI: https://doi.org/10.3390/molecules23112818

Feng WY, Cheang UI, Wong KI, Cheong HI, Meng LR, Fong P. Synergistic activity of Coptis Chinensis and clotrimazole against Candida Albicans. Pharmacological Research - Modern Chinese Medicine. 2023;8:100287. DOI: https://doi.org/10.1016/j.prmcm.2023.100287

Wagle MW, Lobo KN, Rajath KR, Chandrashekar A, Subrahmanyam VM. A Combination approach using Areca nut and Ketoconazole for Treating Cutaneous Candidiasis. Res J Pharm Tech. 2021;14(6):3074-6. DOI: https://doi.org/10.52711/0974-360X.2021.00537

Himratul-Aznita WH, Nor-Zulaila CO, Nurul-Fatihah K. Antifungal activity of dual combination of hydroxychavicol with commercialized agents against oral Candida species. Springerplus. 2016;5(1):1696. DOI: https://doi.org/10.1186/s40064-016-3396-6

Sherweit El-Ahmady, Mohamed El-Shazly, Rola Milad. The Synergetic Efficacy of the Combination of Amphotericin B and Certain Essential Oils against Selected Fungal Clinical Isolates. J App Pharm Sci. 2013;3(04):26-30.

Soulaimani B, Varoni E, Iriti M, Mezrioui NE, Hassani L, Abbad A. Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains. Antibiotics. 2021;10:1049. DOI: https://doi.org/10.3390/antibiotics10091049